Precision medicine researchers at UF Health are among the nation’s leading experts in studying pharmacogenomics and developing strategies to implement precision medicine into practice. Since 2011, UF Health researchers have been studying precision medicine from multiple angles and have been building an evidence-base which supports using genetic information to improve patient care. UF was among six sites chosen for the National Institutes of Health-funded Implementing GeNomics In pracTicE, or IGNITE, Network dedicated to supporting the implementation of genomics in health care and received more than $6 million in IGNITE I funding over five years. In 2018, UF was selected among five sites to lead IGNITE II and further advance the use of genomic information into medical practice.
$9+ million in total competitive funding
300+ peer-reviewed publications
16 full-time faculty
UF College of pharmacy
Center for Pharmacogenomics and Precision Medicine
The center focuses on improving patient outcomes through research, teaching and service focused on genetically-guided drug therapy decision making, drug discovery and drug development. Genotyping and other services are provided to the UF community and beyond.
IGNITE II Research network
Implementing Genomics into Clinical Practice
IGNITE II is a multi-institutional research network funded by the National Institutes of Health. Five institutions, including the University of Florida, have been funded to deliver personalized health care informed by genomics through IGNITE II.
UF Health Clinical Trial
TOPMEDs
TOPMEDs involves a randomized, controlled, pragmatic clinical trial assessing both the real-world effectiveness as well as implementation outcomes using a targeted pharmacogenetic testing panel in several UF Health emergency departments.
